ERG Holding Company LLC

10/06/2026 | Press release | Archived content

Hypoglycemia Risk With Tirzepatide in Type 1 Diabetes

ERG Holding Company LLC published this content on October 06, 2026, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on October 13, 2026 at 12:15 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]